期刊文献+

PET/CT在乳腺癌中的临床应用价值 被引量:1

The value on clinical application of PET/CT on breast cancer
下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤之一,也是导致女性肿瘤患者死亡主要疾病之一,在我国,乳腺癌的发病率呈逐年上升趋势。因此,对乳腺癌早期诊断、准确分期、判断疗效等显得尤为重要。目前,对于乳腺癌的诊断主要依靠乳腺X线摄影术、B超及MRI。乳腺X线摄影术由于敏感性偏低,即使临床体检能够扪及的乳腺癌病灶(大于1cm)仍有10%的漏诊。
出处 《上海医学影像》 2010年第2期156-158,160,共4页 Shanghai Medical Imaging
  • 相关文献

参考文献27

  • 1Fletcher SW,Black W,Harris R.Report of international workshop on screening for breast cancer[J].J Natl Cancer Inst,1993,85(20):1644-1656.
  • 2Jackson VP.The current role of ultrasonography in beast imaging[J].Radiol Clin North Am,1995,33(6):305-311.
  • 3Friedrich M.MRI of the breast:state of the art.[J]Eur Radio,1998,8(5):707-725.
  • 4Scheidhauer K,Scharl A,Pietrzyk U,et al.Quqlitative[18F]FDG Positron emission tomography in primary breast cancer:clinical relevance and practicability[J].Eur J Nucl Med,1996,23(6):618-6123.
  • 5Back A,Schirrmeister H,Kuhn T,et al.FDG uptake in breast cancer:correlation with biological and clinical prognostic parameters[J].Eur J Nucl Med Mol Imag,2002.29(10):1317-1323.
  • 6Kumar R Chauhan A,Zhuang H et al.Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer[J].Breast Cancer Res Treat,2006,98(3):267-274.
  • 7Avril N,Rose C A,Schelling M et al.Breast imaging with Positron emission tomography and fluorine-18 fluorode oxyglucose:use and Limitations[J].J Clin Oncol,2000,18(20):3495-3502.
  • 8Mavi,Urhan M,Yu JQ,et al.Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes[J].J Nucl Med,2006,47(9):1440-446.
  • 9Wang Y,Yu J,Liu J,et al.PET/CT in the diagnosis,of both primar.breast cancer and axllary lymph node metastasis:Initial experience[J].Int J Radiat Oncol Biol Phys,2003,57(2):3625-3625.
  • 10Greco M,Crippa F,Agresti R,et al.Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose:Positron emission tomography:clinical evaluation and alternative management[J].J Nati Cancer Iust,2001,93(8):630-635.

同被引文献18

  • 1修建军,李传福,刘庆伟,赵素红,于德新,张晓明,余志刚.乳腺癌腋窝淋巴结转移的CT评价[J].中华放射学杂志,2005,39(2):169-172. 被引量:33
  • 2邹海东,马榕,余之刚,王成刚,刘庆伟,孙靖中.PET/CT诊断乳腺癌及腋窝淋巴结状态的作用评价[J].外科理论与实践,2006,11(2):108-111. 被引量:7
  • 3Marshall C,Mustafa S,Wheatley DC,et al.A comparison of 18-FDG gamma camera PET,mammography andult rasono graphy in demon strating primary disease in locally advanced breast cancer[J].Nucl Med Commun,2004,25(7):721-5.
  • 4Buscombe JR,Holloway B,Roche N,et al.Position of nuclear medicine modalities in the diagnostic work-up of breast cancer[J].J Nucl Med Mol Imaging,2004,48(2):109-18.
  • 5Kumar R,Alavi A.Fluorodeoxyglucose-PET in the management of breast cancer[J].Radiol Clin North Am,2004,42(6):1113-22.
  • 6vander Hoeven JJ,Hoekstra OS,Comans EF,et al.Determinant sofdiagnostic performance of[F-18]fluoro deoxy glucose position emission tomo graphy for axillary staging in breast cancer[J].Ann Surg,2002,236(5):619-24.
  • 7Gallowitsch HJ,Kresnik E,Gassert J,et al.18 F-fluoro deoxy glucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow2up of patients with breast carcinoma:a comparison to conventional imaging[J].Invest Radiol,2003(38):250-6.
  • 8Kujmar R,Alavia A.Fluorodeoxyglucose-PET in the management of breast cancer[J].Radio Clin N orth Am,2004,42(6):1113-22.
  • 9Kumar R,Chauhan A,Zhuang H,et al.Clinic opathologic factors associated with false negative FDG-PET in primary breast cancer[J].Breast Cancer Res Treat,2006,98(3):267-70.
  • 10Avril N,Rose CA,Schelling M,et al.Breast imaging with Positron emission tomography and fluorine-18 fluorodeoxyglucose:use and imitations[J].J Clin Oncol,2000,18(20):3495-502.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部